AHA Coding Clinic® for HCPCS - 2022 Quarter 4; For Your Information
New CPT Codes for COVID-19 vaccines
The American Medical Association (AMA) has approved new CPT Category I codes for reporting Sars-CoV-2 vaccines. The new bivalent COVID-19 vaccines are different from the primary vaccine series and the previously available booster doses, which were monovalent and only targeted the original Sars-CoV-2 virus. The new bivalent vaccines contain an element of the original strain of Sars-CoV-2 but also contain elements of the omicron subvariants BA.4 and BA.5 to protect better against newer circulating virus strains. The bivalent vaccines are available to patients as young as 5. In the case of either the Pfizer-BioNTech or Moderna bivalent...
Subscribe or sign in to view the full article.
Article Overview
This article covers CPT updates for COVID-19 vaccine reporting, focusing on newly approved product and administration codes for bivalent vaccines, their manufacturer-specific use, and related timing and authorization notes. It is relevant to coding professionals, billing staff, and vaccine program administrators who need to track current AMA and CDC guidance as vaccine coding continues to change.
Why This Topic Matters
Accurate vaccine coding depends on keeping up with newly issued CPT guidance, manufacturer-specific reporting, and effective dates tied to approval status. This article helps readers identify the current scope of reporting changes for COVID-19 vaccine services.
Article Sections
-
Overview of CPT updates for COVID-19 vaccines
Introduces the current CPT reporting changes for SARS-CoV-2 vaccines and explains the general context for the new vaccine products and administration codes.
-
New CPT product and administration codes for COVID-19 vaccines
Presents the newly listed vaccine and administration code information, along with manufacturer, availability timing, and related reporting notes.
-
Guidance and reference sources
Points readers to external AMA and CDC resources for ongoing updates and revised COVID-19 coding guidance.
What You Will Learn
- How recent CPT vaccine updates are organized
- Which broad vaccine reporting topics are addressed
- What types of manufacturer and timing information are included
- Where to look for updated AMA and CDC guidance
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Immunization program administrators
- Compliance teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com